Liraglutide
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Novo Nordisk · Phase 3 · Completed · Enrollment 846
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Lira 3.0 mg: week 56 2.3%
- Lira 1.8 mg: week 56 2%
- Placebo: week 56 -0.1%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.